Possible mechanisms of allogeneic blood transfusion-associated postoperative infection

被引:125
|
作者
Vamvakas, EC
机构
[1] NYU, Med Ctr, Blood Bank, New York, NY 10016 USA
[2] NYU, Med Ctr, Transfus Serv, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Pathol, New York, NY USA
关键词
D O I
10.1053/tmrv.2002.31463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Four possible mechanisms have been reported to underlie the apparent association of allogeneic blood transfusion (ABT) with postoperative bacterial infection. These are (1) a transfusion-related immunomodulatory (TRIM) effect of ABT mediated by immunologically active allogeneic white blood cells (WBCs) that downregulate the recipient's immune function, thereby predisposing to infection; (2) a TRIM effect of ABT mediated by soluble biologic response modifiers released in a time-dependent manner from WBC granules or membranes into the supernatant fluid of red blood cells (RBCs) during storage; (3) a TRIM effect of ABT mediated by soluble HLA peptides that circulate in allogeneic plasma; and (4) a related non-TRIM effect of ABT, whereby ABT causes postoperative organ dysfunction that predisposes to infection. The available clinical studies examining the association of ABT with postoperative infection were not designed to specifically test 1 or more of these 4 hypotheses. Thus, it is difficult to make inferences from the published data about the specific mechanism(s) that may underlie the purported association of ABT with infection. To permit such inferences, future studies of the association of ABT with postoperative infection should consider 2 outcomes (ie, postoperative organ dysfunction in addition to postoperative infection), as well as 3 possible exposures (ie, allogeneic WBCs, soluble biologic response modifiers originating in WBC granules or membranes, and/or soluble HLA molecules circulating in allogeneic plasma). Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:144 / 160
页数:17
相关论文
共 50 条
  • [1] TRANSFUSION-ASSOCIATED HIV-INFECTION
    FREYWETTSTEIN, M
    TRANSFUSION MEDICINE 1988 - INFECTIONS, PLASMA PRODUCTS, TRANSPLANTATIONS, ANTIBODIES, 1989, 24 : 18 - 26
  • [2] TRANSFUSION-ASSOCIATED HIV-INFECTION
    GURTLER, LG
    EBERLE, J
    BADER, L
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1994, 21 : 7 - 10
  • [3] TRANSFUSION-ASSOCIATED HIV INFECTION IN SWITZERLAND
    FREYWETTSTEIN, M
    LEDER, A
    SCHUTZE, M
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (05) : 149 - 153
  • [4] BLOOD TRANSFUSION-ASSOCIATED RELAPSING FEVER
    NADELMAN, RB
    WORMSER, GP
    SHERER, C
    TRANSFUSION, 1990, 30 (04) : 380 - 380
  • [5] Prosthetic joint infection:: Possible role of perioperative allogeneic blood transfusion
    Munoz, Manuel
    Naveira, Enrique
    Cuenca, Jorge
    Garcia-Erce, Jose Antonio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (09): : 595 - 596
  • [6] Case report of a transfusion-associated hepatitis A infection
    Hughes, Jonathan A.
    Fontaine, Magali J.
    Gonzalez, Christopher L.
    Layon, Arlene G.
    Goodnough, Lawrence Tim
    Galel, Susan A.
    TRANSFUSION, 2014, 54 (09) : 2202 - 2206
  • [7] Transfusion-associated Babesia gibsoni infection in a dog
    Stegeman, JR
    Birkenheuer, AJ
    Kruger, JM
    Breitschwerdt, EB
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2003, 222 (07) : 959 - +
  • [8] TRANSFUSION-ASSOCIATED HIV-INFECTION - REPLY
    WARD, JW
    HOLMBERG, SD
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (11): : 775 - 775
  • [9] Transfusion-associated hepatitis C virus infection
    Minton, J
    REVIEWS IN MEDICAL MICROBIOLOGY, 1998, 9 (04) : 207 - 215
  • [10] EFFECTS OF TRANSFUSION-ASSOCIATED HIV-INFECTION
    TUFFS, A
    LANCET, 1993, 342 (8877): : 980 - 980